Atlantic Diagnostic Laboratories Launches Revolutionary Urine-Based Diagnostic Test to Detect Precursor to Colon Cancer

Atlantic Diagnostic Laboratories (ADL), today announced the official launch of PolypDx™, a non-invasive urine-based diagnostic test for detection of adenomatous polyps, the precurser to colorectal cancer. "ADL, with it's extensive LC/MS/MS expertise, is very excited to be offering the PolypDx™ non-invasive urine test for its official launch into America," said Aaron Domenico, Chief Operating Officer of ADL. "Colorectal cancer is a leading cause of death in the United States. With early detection in the adenamatous polyp stage, this form of cancer is preventable."